Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Aimei Health Technology Co., Ltd Ordinary Share (AFJK)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: AFJK (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit 8.65% | Avg. Invested days 276 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  5.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 09/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 68.26M USD | Price to earnings Ratio 48.48 | 1Y Target Price - |
Price to earnings Ratio 48.48 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 10.24 - 11.20 | Updated Date 06/29/2025 |
52 Weeks Range 10.24 - 11.20 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.23 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -0.92% | Return on Equity (TTM) - |
Valuation
Trailing PE 48.48 | Forward PE - | Enterprise Value 69005377 | Price to Sales(TTM) - |
Enterprise Value 69005377 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding 6121730 | Shares Floating 3988921 |
Shares Outstanding 6121730 | Shares Floating 3988921 | ||
Percent Insiders 33.6 | Percent Institutions 69.71 |
Upturn AI SWOT
Aimei Health Technology Co., Ltd Ordinary Share
Company Overview
History and Background
Aimei Health Technology Co., Ltd Ordinary Share is not a publicly traded US stock. Therefore, information related to its history, milestones, and evolution as a US-listed entity is not applicable.
Core Business Areas
Leadership and Structure
Not Applicable as there is no US listing
Top Products and Market Share
Key Offerings
Market Dynamics
Industry Overview
As Aimei Health Technology Co., Ltd Ordinary Share is not a US-listed entity, its industry overview in the context of the US market is not applicable.
Positioning
Not Applicable
Total Addressable Market (TAM)
Not Applicable
Upturn SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
Competitors and Market Share
Key Competitors
Competitive Landscape
Not Applicable
Growth Trajectory and Initiatives
Historical Growth: Not Applicable
Future Projections: Not Applicable
Recent Initiatives: Not Applicable
Summary
Aimei Health Technology Co., Ltd Ordinary Share is not a US-listed stock, making it impossible to analyze its performance and market dynamics in the context of the US stock market. Consequently, assessments of its strengths, weaknesses, growth trajectory, and competitive positioning within the US market are irrelevant. It's crucial to verify that it is a US publicly traded company before performing analysis.
Peer Comparison
Sources and Disclaimers
Data Sources:
Disclaimers:
The analysis is based on the premise that Aimei Health Technology Co., Ltd Ordinary Share would be a US publicly listed company, which it is not. The information provided is for illustrative purposes only and should not be used for investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aimei Health Technology Co., Ltd Ordinary Share
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2024-01-22 | CEO, Secretary & Director Mr. Junheng Xie | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | Website |
Full time employees - | Website | ||
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.